Combined analyses of RNA-sequence and Hi-C along with GWAS loci-A novel approach to dissect keloid disorder genetic mechanism.

Jia Huang, Xiaobo Zhou, Wenbo Wang, Guangdong Zhou, WenJie Zhang, Zhen Gao, Xiaoli Wu, Wei Liu
Author Information
  1. Jia Huang: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ORCID
  2. Xiaobo Zhou: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  3. Wenbo Wang: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ORCID
  4. Guangdong Zhou: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  5. WenJie Zhang: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  6. Zhen Gao: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ORCID
  7. Xiaoli Wu: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ORCID
  8. Wei Liu: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Abstract

Keloid disorder is a tumour-like disease with invasive growth and a high recurrence rate. Genetic contribution is well expected due to the presence of autosomal dominant inheritance and various genetic mutations in keloid lesions. However, GWAS failed to reveal functional variants in exon regions but single nucleotide polymorphisms in the non-coding regions, suggesting the necessity of innovative genetic investigation. This study employed combined GWAS, RNA-sequence and Hi-C analyses to dissect keloid disorder genetic mechanisms using paired keloid tissues and normal skins. Differentially expressed genes, miRNAs and lncRNAs mined by RNA-sequence were identified to construct a network. From which, 8 significant pathways involved in keloid disorder pathogenesis were enriched and 6 of them were verified. Furthermore, topologically associated domains at susceptible loci were located via the Hi-C database and ten differentially expressed RNAs were identified. Among them, the functions of six molecules for cell proliferation, cell cycle and apoptosis were particularly examined and confirmed by overexpressing and knocking-down assays. This study firstly revealed unknown key biomarkers and pathways in keloid lesions using RNA-sequence and previously reported mutation loci, indicating a feasible approach to reveal the genetic contribution to keloid disorder and possibly to other diseases that are failed by GWAS analysis alone.

References

  1. Dis Markers. 2015;2015:325176 [PMID: 26612965]
  2. Exp Dermatol. 2012 Apr;21(4):277-80 [PMID: 22417303]
  3. Int J Biol Sci. 2013 Oct 25;9(10):1032-42 [PMID: 24250248]
  4. Prog Histochem Cytochem. 2016 Nov;51(3-4):51-58 [PMID: 27908506]
  5. Annu Rev Pathol. 2011;6:49-69 [PMID: 20887192]
  6. J Biomed Mater Res A. 2019 Jul;107(7):1366-1378 [PMID: 30724474]
  7. J Med Genet. 2004 Jul;41(7):e95 [PMID: 15235038]
  8. Elife. 2019 Apr 16;8: [PMID: 30990165]
  9. Nat Commun. 2018 Feb 21;9(1):750 [PMID: 29467363]
  10. Exp Ther Med. 2016 Dec;12(6):3633-3641 [PMID: 28101157]
  11. Nat Genet. 2010 Sep;42(9):768-71 [PMID: 20711176]
  12. Oncol Lett. 2019 Apr;17(4):3751-3764 [PMID: 30881497]
  13. Adv Sci (Weinh). 2019 Jul 22;6(18):1900972 [PMID: 31559135]
  14. Br J Cancer. 2000 Feb;82(4):818-22 [PMID: 10732752]
  15. Sci Rep. 2020 Jan 16;10(1):521 [PMID: 31949263]
  16. J Biol Chem. 1991 Oct 15;266(29):19650-8 [PMID: 1918072]
  17. Biol Reprod. 2010 Sep;83(3):347-58 [PMID: 20505164]
  18. Cell Transplant. 2017 Nov;26(11):1822-1829 [PMID: 29338386]
  19. Mol Med Rep. 2016 Sep;14(3):2045-51 [PMID: 27431002]
  20. Int J Med Sci. 2013;10(4):344-54 [PMID: 23471552]
  21. J Clin Invest. 2009 Aug;119(8):2171-83 [PMID: 19620787]
  22. J Med Genet. 2000 Mar;37(3):210-2 [PMID: 10777362]
  23. J Am Coll Clin Wound Spec. 2016 Nov 30;7(1-3):1-7 [PMID: 28053861]
  24. PLoS One. 2013 May 07;8(5):e62377 [PMID: 23667473]
  25. Nat Commun. 2019 Sep 27;10(1):4422 [PMID: 31562322]
  26. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007 Jul;21(7):698-701 [PMID: 17694657]
  27. Nat Commun. 2018 Mar 12;9(1):1028 [PMID: 29531215]
  28. Nat Commun. 2017 Jun 06;8:15789 [PMID: 28585551]
  29. Nat Med. 2019 Jan;25(1):152-164 [PMID: 30510257]
  30. Aging (Albany NY). 2020 Jul 11;12(14):14775-14790 [PMID: 32652519]
  31. J Cell Biol. 2003 Sep 1;162(5):833-42 [PMID: 12952936]
  32. Blood. 2018 Apr 12;131(15):1639-1653 [PMID: 29463564]
  33. Hepatology. 2018 Mar;67(3):940-954 [PMID: 29023935]
  34. Eur J Hum Genet. 2017 Nov;25(11):1286-1289 [PMID: 28792001]
  35. Cell Res. 2020 Oct;30(10):854-872 [PMID: 32457396]
  36. Int J Clin Exp Pathol. 2015 Jan 01;8(1):337-44 [PMID: 25755720]
  37. Elife. 2019 May 14;8: [PMID: 31084714]
  38. Sci Rep. 2016 May 19;6:26396 [PMID: 27193598]
  39. Front Immunol. 2019 Aug 07;10:1810 [PMID: 31440236]
  40. Arch Dermatol Res. 2010 Jul;302(5):319-39 [PMID: 20130896]
  41. Exp Cell Res. 2019 Nov 1;384(1):111613 [PMID: 31494095]
  42. EMBO J. 2003 Sep 15;22(18):4728-37 [PMID: 12970185]
  43. Br J Cancer. 2001 Nov 2;85(9):1383-6 [PMID: 11720478]
  44. Front Cell Neurosci. 2017 Dec 12;11:396 [PMID: 29311829]
  45. J Pathol Clin Res. 2016 Jan 21;2(1):41-52 [PMID: 27499915]
  46. Elife. 2018 Jun 01;7: [PMID: 29856313]
  47. Int J Environ Res Public Health. 2018 Mar 13;15(3): [PMID: 29533992]
  48. Biochim Biophys Acta. 2002 Nov 13;1579(1):18-25 [PMID: 12401215]
  49. J Immunol. 2010 Aug 15;185(4):2502-15 [PMID: 20624949]
  50. J Mol Med (Berl). 2016 Oct;94(10):1181-1194 [PMID: 27339758]
  51. Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):2769-2784 [PMID: 29751081]
  52. J Cell Mol Med. 2019 Sep;23(9):5907-5919 [PMID: 31304680]
  53. Toxins (Basel). 2019 May 02;11(5): [PMID: 31052539]
  54. Nat Commun. 2019 Sep 25;10(1):4353 [PMID: 31554795]
  55. Sci Adv. 2018 Aug 15;4(8):eaat2142 [PMID: 30116782]
  56. BMC Dermatol. 2009 Jul 28;9:8 [PMID: 19638218]
  57. J Exp Clin Cancer Res. 2020 May 28;39(1):96 [PMID: 32466797]
  58. J Immunol Res. 2018 Feb 8;2018:3696914 [PMID: 29577047]
  59. Nat Commun. 2019 Sep 19;10(1):4267 [PMID: 31537805]
  60. Biomed Rep. 2015 May;3(3):333-342 [PMID: 26137232]

MeSH Term

Genome-Wide Association Study
Humans
Keloid
MicroRNAs
Polymorphism, Single Nucleotide
RNA, Long Noncoding

Chemicals

MicroRNAs
RNA, Long Noncoding

Word Cloud

Created with Highcharts 10.0.0keloiddisordergeneticGWASRNA-sequenceHi-CcontributionlesionsfailedrevealregionsstudyanalysesdissectusingexpressedidentifiedpathwayslocicellapproachKeloidtumour-likediseaseinvasivegrowthhighrecurrencerateGeneticwellexpectedduepresenceautosomaldominantinheritancevariousmutationsHoweverfunctionalvariantsexonsinglenucleotidepolymorphismsnon-codingsuggestingnecessityinnovativeinvestigationemployedcombinedmechanismspairedtissuesnormalskinsDifferentiallygenesmiRNAslncRNAsminedconstructnetwork8significantinvolvedpathogenesisenriched6verifiedFurthermoretopologicallyassociateddomainssusceptiblelocatedviadatabasetendifferentiallyRNAsAmongfunctionssixmoleculesproliferationcycleapoptosisparticularlyexaminedconfirmedoverexpressingknocking-downassaysfirstlyrevealedunknownkeybiomarkerspreviouslyreportedmutationindicatingfeasiblepossiblydiseasesanalysisaloneCombinedalongloci-Anovelmechanism

Similar Articles

Cited By